Table. 1—
Mucoactive drugs |
Potential mechanism of action |
Expectorants | |
Hypertonic saline | Increases secretion volume and/or hydration |
Guaifenesin | Stimulates secretion and reduces mucus viscosity |
Mucoregulators | |
Carbocysteine | Metabolism of mucus producing cells, antioxidant and anti-inflammatory effects, modulates mucus production |
Anticholinergic agents | Decreases secretion volume |
Glucocorticoids | Reduces airway inflammation and mucin secretion |
Macrolide antibiotics | Reduces airway inflammation and mucin secretion |
Mucolytics | |
N-Acetylcysteine | Breaks disulphide bonds linking mucin polymers |
Antioxidant and anti-inflammatory effects | |
N-Acystelyn | Increases chloride secretion and breaks disulphide bonds |
Erdosteine | Modulates mucus production and increases mucociliary transport |
Dornase alfa | Hydrolyses the DNA in mucus and reduces viscosity in the lungs |
Gelsolin | Severs actin filament cross-links |
Thymosin β4 | Severs actin filament cross-links |
Dextran | Breaks hydrogen bonds and increases secretion hydration |
Heparin | Breaks both hydrogen and ionic bonds |
Mucokinetics# | |
Bronchodilators | Improves cough clearance by increasing expiratory flow |
Surfactants | Decreases sputum/mucus adhesiveness |
Ambroxol | Stimulates surfactant production and inhibits neuronal sodium channels |
#: also referred to as cough clearance promoters.